Lapatinib Ditosylate

Product No	Price	Quantity	Subtotal
L0360-10mg	$207.00
L0360-25mg	$331.20
L0360-100mg	$965.90
	Total

E-mail to a friend

Description

A treatment FDA approved for breast cancer. It is used in patients whose cancer is HER2 positive. Used for treatment of solid tumors and is an ATP competitive epidermal growth factor and HER2 dual tyrosine kinase inhibitor.

More information about Protein Kinase Inhibitors

Specifications

Cas No.	388082-78-8
Product ID	L0360
Product Name	Lapatinib Ditosylate
Formula Wt.	925.46
Melting Point	236-259^oC
Solubility	Slightly in DMSO
Store Temp	Ambient
References	Feng, Yu-fei. Zhongguo Xinyao Zazhi (2007), 16(23), 1990-1993. Nelson, M. H. Therapeutics and Clinical Risk Management (2007), 3(4), 665-673.